Skip to main content

Table 3 Joinpoint analysis of age-adjusted mortality rates per 100 000, AYAs aged 15–39 years in Western Australia, 1982–2005

From: Cancer incidence and mortality trends in Australian adolescents and young adults, 1982–2007

 

Mortality rates, Males

Mortality rates, Females

 

Trend 1

Trend 1

Trend 2

Diagnostic Groups

Period

APC 95% CI

Period

APC 95% CI

Period

APC 95% CI

All Tumours

82 − 05

−2.6* (-3.3; -2.0)

82 − 05

−4.6* (-5.1; -4.1)

  

Leukaemia

82 − 05

−3.6* (-5.9; -1.2)

82 − 05

−3.8* (-6.1; -1.5)

  

   Myeloid

82 − 05

−5.6* (-8.0; -3.1)

82 − 05

−5.0* (-8.3; -1.6)

  

   Lymphocytic

82 − 05

1.6 (-1.5; 4.8)

82 − 05

−2.2 (-5.3; -0.9)

  

Lymphoma a

82 − 05

−5.4* (-7.4; -3.4)

82 − 05

−4.9* (-7.7; -2.0)

  

   NHL

82 − 05

−4.8* (-7.1; -2.5)

82 − 05

−4.5* (-7.3; -1.7)

  

CNS

82 − 05

−3.1* (-4.8; -1.4)

82 − 05

−4.6* (-6.9; -2.1)

  

Bone

82 − 05

−1.8 (-5.0; 1.5)

82 − 05

4.3* (-0.4; 9.2)

  

Soft Tissue

82 − 05

−4.7* (-7.6; 1.8)

82 − 05

−3.7* (-7.0; -0.2)

  

Germ Cell a

82 − 05

−8.2* (-10.5;-5.8)

82 − 05

−1.3 (-6.1; 3.6)

  

   Gonadal

82 − 05

−7.7* (-10.3;-5.1)

    

Melanoma

82 − 05

−5.5* (-7.5; -3.4)

82 − 05

−10.9* (-13.5;-8.2)

  

Carcinoma a

82 − 05

−2.4* (-3.4; -1.5)

82 − 96

−3.0* (-4.2; -1.7)

96 − 05

−8.2* (-10.7; -5.5)

   Breast

na

na

82 − 96

−3.0* (-4.2; -1.3)

96 − 05

−14.4* (-18.4; -9.9)

   Colon & Rectum

82 − 05

−2.1* (-4.0; -0.1)

82 − 05

−2.3* (-3.7;-0.8)

  

   Ovary

na

na

82 − 05

−2.6 (-5.5; -0.5)

  

   Lung

82 − 05

−2.8* (-5.2; -0.3)

82 − 05

−0.9* (-1.3; 3.1)

  

   Cervix Uteri

na

na

82 − 05

−6.8* (-8.2; -5.3)

  

   Lip & Oral Cavity

82 − 05

−3.4* (-5.5; -1.3)

    
  1. * The annual percentage change (APC) is statistically significantly different from 0 (p < 0.05).
  2. a Data for HL, non-gonadal germ cells and thyroid cancers and lip/oral in females were not reported due to low effective sample size less than 95% CI, 95% confidence interval.